Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Current Opinion in Organ Transplantation|June 29, 2011
Kidney paired donation: advancements and future directionsJeremy M Blumberg, H Gritsch, Jeffrey L Veale
Haemophilia : the Official Journal of the World Federation of Hemophilia|September 24, 2004
FEIBA: mode of actionP L Turecek, K Váradi, H Gritsch, et al.
Thrombosis and Haemostasis|March 1, 1997
Assessment of bleeding for the evaluation of therapeutic preparations in small animal models of antibody-induced hemophilia and von Willebrand diseaseP L Turecek, H Gritsch, G Richter, et al.
Vox Sanguinis|October 26, 1999
Factor Xa and prothrombin: mechanism of action of FEIBAP L Turecek, K Varadi, H Gritsch, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|June 30, 2016
A world-wide survey and field study in clinical haemostasis laboratories to evaluate FVIII:C activity assay variability of ADYNOVATE and OBIZUR in comparison with ADVATEP L Turecek, S Romeder-Finger, C Apostol, et al.
Seminars in Thrombosis and Hemostasis|September 8, 2001
Recombinant von Willebrand factor: preclinical developmentB Plaimauer, U Schlokat, P L Turecek, et al.
The Journal of Urology|May 29, 2003
Quality of life, pain and return to normal activities following laparoscopic donor nephrectomy versus open mini-incision donor nephrectomyKent T Perry, Stephen J Freedland, Jim C Hu, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|April 24, 1999
Continuous infusion of FVIII and FIX concentrates: in vitro analysis of clinically relevant parametersK B Thomas, W Urbancik, P L Turecek, et al.
Blood|November 14, 1997
In vivo characterization of recombinant von Willebrand factor in dogs with von Willebrand diseaseP L Turecek, H Gritsch, L Pichler, et al.
Hamostaseologie|September 19, 2009
Development of a plasma- and albumin-free recombinant von Willebrand factorP L Turecek, A Mitterer, H P Matthiessen, et al.
Pageof 2